Suspicious cells can often go overlooked using traditional Pap smear analysis methods—due to healthcare worker shortages and general human error—but Hologic said studies have found that its Genius ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the ThinPrep® Genesis processor for cytology slide and molecular test preparation has received a CE IVD mark in ...
MARLBOROUGH, Mass., May 3, 2016 /PRNewswire/ -- A new cervical cancer screening study demonstrates that Pap+HPV Together™ (co-testing) remains the most effective strategy for detecting high-grade ...
BEDFORD, Mass., April 16, 2015 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today commented on an important cervical cancer screening study i published on-line this week in Cancer Cytopathology, a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Marlborough women’s health device manufacturer Hologic has won a federal approval for a device the company says can analyze pap tests in 90 seconds. The company announced last week its premarket ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
You’ve probably never heard of Hologic, but your next breast exam, Pap test, or COVID/flu check might depend on it. Investors are watching the stock, doctors swear by the tech. Here’s what you’re not ...
Hologic, Inc. (Nasdaq: HOLX) announced today that the ThinPrep® Genesis processor for cytology slide and molecular test preparation has received a CE IVD mark in Europe. The system features increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results